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Abstract
Kidney transplantation is the treatment of choice for end-
stage renal disease. The evaluation of graft function 
is mandatory in the management of renal transplant 
recipients. Glomerular filtration rate (GFR), is generally 
considered the best index of graft function and also 
a predictor of graft and patient survival. However 
GFR measurement using inulin clearance, the gold 
standard for its measurement and exogenous markers 
such as radiolabeled isotopes (51Cr EDTA, 99mTc DTPA or 
125I Iothalamate) and non-radioactive contrast agents 
(Iothalamate or Iohexol), is laborious as well as expensive, 
being rarely used in clinical practice. Therefore, endogenous 
markers, such as serum creatinine or cystatin C, are used 
to estimate kidney function, and equations using these 
markers adjusted to other variables, mainly demographic, 
are an attempt to improve accuracy in estimation of GFR 
(eGFR). Nevertheless, there is some concern about the 
inability of the available eGFR equations to accurately 
identify changes in GFR, in kidney transplant recipients. 
This article will review and discuss the performance 
and limitations of these endogenous markers and their 
equations as estimators of GFR in the kidney transplant 
recipients, and their ability in predicting significant clinical 
outcomes.
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Core tip: An accurate evaluation of allograft function 
is essential in the management of kidney transplant. 
Glomerular filtration rate (GFR), is generally considered 
the best index of graft function. Endogenous markers, 
such as serum creatinine or cystatin C, are used to 
estimate kidney function, and equations using these 
markers adjusted to other variables, are an attempt 
to improve accuracy in estimation of GFR. This article 
will review and discuss the performance and limitations 
of these endogenous markers and their equations as 
estimators of GFR in the kidney transplant recipients, 
and their ability in predicting clinical outcomes.
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INTRODUCTION
Kidney transplantation is the treatment of choice for 
end-stage renal disease. A successful kidney transplant 
improves the quality of life, reduces the mortality risk 
for most patients and is less costly when compared 
with maintenance dialysis[1-3]. The signiﬁcant progress 
that has occurred over the last two decades in renal 
transplantation is mostly driven by improvements in 
short-term graft survival whereas long-term outcomes 
remained largely unchanged[4,5]. Nowadays, with the 
traditional short-term outcomes, namely the 1-year graft 
and patient survival rates in excess of 90% and 1-year 
acute rejection rate of less than 15%, the question 
arises if any further improvements are possible or even 
necessary[6]. However, these outstanding results have 
failed to anticipate long-term survival, so it becomes clear 
that identiﬁcation of new, short-term end points capable 
of correlating with long-term graft outcome is necessary[7] 
ideally translating in longer graft maintenance.
Renal allograft function seems to be a tempting 
candidate as surrogate marker for research studies 
on transplantation[8], also for the assessment of new 
drugs[9,10], although its use as an outcome marker for 
graft loss is controversial[11,12]. In generally, the glomerular 
ﬁltration rate (GFR), is considered to be the best index 
of overall kidney function[13,14], also an indicator of long-
term graft survival[15], and an independent risk factor 
for cardiovascular mortality[16,17], the primary cause of 
death in kidney transplant recipients[17,18]. Of note, like 
in non-transplant chronic kidney disease, prevalence of 
complications related to loss of renal function such as 
hypertension, anemia and abnormal mineral metabolism 
increases signiﬁcantly as the GFR declines[19]. Another 
important point is that the decline in GFR is also related 
with increased health care costs, and over the two 
years, transplantation was both more effective and less 
costly than dialysis[2,3]. Therefore, an accurate evaluation 
of renal allograft function is crucial in the clinical 
management of kidney transplant recipients.
Methods to measure GFR using exogenous markers, 
such as inulin clearance, the gold standard, and others 
such as radiolabeled isotopes (51Cr EDTA, 99mTc DTPA or 
125I Iothalamate) and non-radioactive contrast agents 
(Iothalamate or Iohexol), are laborious as well as 
expensive, being rarely used in clinical practice. Therefore, 
endogenous markers, such as serum creatinine (SCr) or 
cystatin C (CyC), are used to estimate kidney function. 
Mathematical formulas employing these markers 
adjusted to other variables (mainly demographic) are an 
effort to ameliorate GFR estimation (eGFR) accuracy.
However, there is some concern about the accuracy 
of the available eGFR equations in kidney transplant 
recipients and guidelines still provide conflicting 
recommendations about GFR estimation methods in 
this population[20].
In this article, we aim to review the performance 
and limitations of these endogenous markers and their 
equations as estimators of GFR in the kidney transplant 
recipients, and their ability in predicting significant 
clinical outcomes.
ENDOGENOUS MARKERS
SCr 
SCr concentration is the best known and most 
commonly used marker for estimation of GFR, since 
it was ﬁrst described as a GFR marker in 1937[21], and 
SCr analysis is inexpensive and generally accessible. 
Creatinine is a breakdown product of creatinephosphate 
in muscle tissue, produced at a relatively constant rate, 
depending on the muscle mass, and filtered in the 
glomerulus but also actively secreted in the proximal 
tubule[22]. Tubular secretion contributes normally to 
10% of renal Cr removal, but increases when GFR 
decreases[23], causing SCr to remain in the normal 
range until GFR drops below 60-70 mL/min. Some Cr 
is also incorporated from the diet. Ingestion of meat 
contributes substantially to the urinary Cr excretion, 
both as a result of expansion of the total creatine pool 
and as a result of gastrointestinal absorption of Cr[22]. 
Thus, multiple factors contribute to reduce the accuracy 
of SCr as an indicator of the GFR, including sex, age, 
race, muscle mass and dietary protein intake.
Particularly, in renal transplantation there are other 
determinants that may interfere with Cr metabolism 
such as corticosteroids, which have a direct catabolic 
effect[24] and cause a changed muscle mass ratio 
to total body weight[25]. Catabolic illnesses such as 
infection and acute rejection, and prolonged dialysis, 
can also be partly responsible[26]. 
Cr tubular secretion can be blocked by some drugs such 
as trimethoprim, commonly used in kidney transplantation[27]. 
Also, chronic rejection and acute tubular necrosis, can 
contribute, because tubular secretion of creatinine is 
reduced.
Because Cr secretion is not predictable, the GFR 
can decrease to nearly half the normal value before 
the SCr increases[13], with remarkable consequences 
in kidney transplant outcome, where subclinical 
progressive damage, such as calcineurin toxicity and 
rejection will not be early identiﬁed. Several studies in 
kidney transplantation demonstrated that the SCr and 
GFR were barely correlated[26,28]. 
In addition, SCr measurement by the most common 
method (Jaffé) is subject to interferences by chromogens 
such as bilirubin, glucose and uric acid, and the 
enzymatic method is prone to interference by bilirubin 
and some antibiotics. Considerable variations between 
SCr assays calibration may also cause inaccuracies in its 
determination[29]. An attempt to standardize measurement 
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has been recently introduced by adoption of a common 
calibration to isotope dilution mass spectrophotometry 
standard (IDMS) with substantial improvement and 
traceability of SCr measurements[30].
Nonetheless, SCr is recommended as a screening 
test for changes in allograft function[31], adjustments 
of immunosuppressive drugs[32], and it was shown that 
SCr by itself may be a predictor of long-term graft and 
patient survival[33]. 
Creatinine clearance 
Creatinine clearance (CCr) as measured from 24-h urine 
collection is often used in clinical practice to calculate 
GFR, but it overestimates GFR due to the secretion of 
Cr by the renal tubules and the inherent limitations of 
SCr as a kidney marker. However, this calculation does 
not correct for tubular secretion, and overestimates 
GFR also in transplant populations[28,34,35], with additional 
errors in urine collection. Measurement of CCr using this 
method becomes more reliable after the administration 
of cimetidine, which inhibits tubular secretion[36], but 
still does not supply additional knowledge about renal 
function than other Cr-based methods[13,14].
Serum CyC
CyC is a 122-amino acid, 13-kDa protein that is a 
member of a family of competitive inhibitors of lysosomal 
cysteine proteinases. Its functions include involvement 
in extracellular proteolysis, immune modulation, and 
antibacterial and antiviral activities.
CyC has certain characteristics that make it an 
acceptable candidate as a kidney function marker, 
including a constant production rate, free glomerular 
filtration, complete reabsorption and catabolism by the 
proximal tubules with no reabsorption, and no tubular 
secretion[37].
Several clinical data demonstrated that serum CyC 
levels correlate better with GFR than does Cr alone, 
especially at higher levels of GFR, and it was also thought 
to be less influenced by certain demographic factors 
such as age, race, gender, or muscle mass compared 
with SCr[38,39]. However, some emerging new data have 
shown that serum CyC may be influence by these and 
other variables.
A recent study concluded that CyC was 9% lower in 
women and 6% higher in blacks for a given GFR[40]. In 
a cross-sectional study, Knight et al[41], found that older 
age, male gender, greater weight, greater height, current 
cigarette smoking, and higher serum C-reactive protein 
levels were independently associated with higher serum 
CyC levels after adjusting for CCr.
Moreover, in certain clinical settings, CyC level may be 
biased as a marker of kidney function, such as in patients 
with uncontrolled thyroid disease, rapid cell turnover, and 
those under steroid therapy[42], like kidney transplant 
recipients. Also, CyC is quite costly and unavailable in 
many transplant centers.
GFR ESTIMATION FROM SCR BASED 
EQUATIONS
To overcome some of the limitations of Cr as a marker 
for GFR, several formulas have been constructed to 
correct for the influences of weight, age, gender and/or 
race[26,43-46].
Some of these equations have been evaluated in 
renal transplant patients, and the most commonly used 
are the Modification of Diet in Renal Disease (MDRD) 
study[44], Cockcroft-Gault[43], and Nankivell[26] equations. 
The KDIGO position statement includes the proposal 
that Cr-based eGFR equations should be used to 
evaluate renal function in the everyday management of 
renal transplant recipients[14].
The Cockcroft-Gault equation was derived in 236 
(96% male) hospitalized patients with a wide range 
of GFR values[43]. The MDRD equation, published in 
1999 were derived in 1628 patients with chronic kidney 
disease (mean GFR, 40 mL/min per 1.73 m2)[44], and 
this was simpliﬁed in 2000[47] and reexpressed in 2005, 
after standardization of the SCr assays to the reference 
method using IDMS[48,49]. The Nankivell equation is 
the only one that was derived from kidney transplant 
recipients[26], however some of these transplant patients 
were in an early post-transplant phase or with acute 
dysfunction, which has implications in prediction of GFR. 
More recently, a new formula was published by the 
chronic kidney disease epidemiology collaboration (CKD-
EPI)[50], to overcome the systematic underestimation 
of GFR and lack of precision of the MDRD formulas in 
patients with relatively well-preserved kidney function, 
but only 4% of the CKD-EPI derivation cohort consisted 
of organ transplant recipients. 
PERFORMANCE OF CREATININE-BASED 
GFR ESTIMATION EQUATIONS IN 
KIDNEY TRANSPLANTATION
To certify graft function as a valid surrogate marker, we 
must know for certain that we use a solid measure of 
kidney function.
The eGFR equations were an alternative to estimate 
GFR in clinical context, as they allow us to overpass 
some of the limitations of the SCr[51].
To determine the performance of a given eGFR equation 
the K/DOQI guidelines[13] proposed a methodological 
approach according to simple and reproducible criteria: 
“BIAS”, “PRECISION” and “ACCURACY”. The absolute 
BIAS expresses the systematic deviation from the gold 
standard measurement of GFR, and was given by the 
mean difference between estimated GFR and gold standard 
clearance (true GFR). The relative BIAS, hereafter named 
percent BIAS, is expressed as the proportion of true GFR 
represented by the absolute bias, and was calculated as: 
absolute BIAS/true GFR × 100. PRECISION expresses the 
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therefore assessment of the equation performance in 
these subgroups is limited[57].
However we can’t ignore that SCr levels are affected 
by factors besides GFR, and several studies suggest 
worse stage-based care in kidney transplant patients 
compared with native kidney diseases[59,60], so any 
eGFR equations based on SCr still have limitations.
PERFORMANCE OF CYSTATIN-BASED 
GFR ESTIMATION EQUATIONS IN 
KIDNEY TRANSPLANTATION
As with SCr, it is the CyC-based GFR, rather than the 
CyC itself, that is of greater clinical interest. Over the 
last decade, several serum CyC-based equations have 
been developed and proposed to estimate the GFR[61-67]. 
Only two of these equations (Rule et al[64] and Le Bricon 
et al[67]) were exclusively derived from a population of 
kidney transplant recipients.
Several studies in the renal transplant population, 
showed discordant results with some indicate advantage 
of CyC-based equations over Cr-based equations, whereas 
others showed no superiority of CyC over SCr[20,34,68]. 
One of the limitations of CyC-based eGFR formulas in 
this population is that the treatment with corticosteroids 
increases CyC levels by increasing the production of 
CyC[69]. Although the KDIGO recommendations on kidney 
transplantation comment the possible interest of using 
CyC to GFR estimation, they do not advocated its regular 
clinical use, due to the paucity of validation studies in this 
group of patients[20].
A recent systematic review[70], identiﬁed 10 studies, 
evaluating the accuracy of 14 different CyC-based eGFR 
equations in renal transplant recipients. The authors 
conclude that the Le Bricon equation[67] was the highest 
accurate, and the majority of the CyC-based equations 
exhibited 30% and 50% accuracy improvements 
compared with the Cr-based MDRD equation. However, 
as with the Cr equations, there was substantial 
variability between the studies. Much of this variability is 
consequence of different study populations, differences 
in the GFR reference standard measurement, and in 
variation in the calibrators for the CyC measurement, 
and this latter contributes to the greatest source of 
variation. Standardized reference material for CyC has 
already been developed[71], but none of the studies 
involved in this analysis[70], adopted this methodology.
In 2008 a new Cr- and CyC-based formula (CKD-EPI 
CyC equation) was developed[40], which besides serum 
CyC includes the variables of gender, age and race, 
and seems more accurate than the formulas based 
on Cr or CyC alone, but this formula requires further 
testing in various patients groups. 
Recently, the CyC-based estimating equations 
were re-expressed for use with the standardized CyC 
reference material (ERM-DA47/IFCC)[72]. These and 
the equations with CyC in combination with SCr[40], 
improved in 2012 with lesser bias at GFR > 60 mL/min 
variability or dispersion of predictions around the true GFR 
and corresponds to the standard deviation of the difference 
between the true and estimated GFR. The distribution of the 
differences between estimated and true GFR accounts for 
the ACCURACY of the GFR estimates (e.g., 30% accuracy 
is the proportion of predicted GFR within ± 30% of the true 
GFR).
In several studies in kidney transplantation, the 
efficiency of MDRD, Cockcroft-Gault and Nankivell 
equations has been consistently reviewed[52], with a 
signiﬁcant heterogeneity between studies, with low 
precision inducing limited accuracies, and this can be 
attributed to varied patient characteristics, differences 
in measure GFR methods and Cr assay calibration and, 
potentially, some inherent differences in this specific 
population of transplant recipients[52]. In the majority 
of these studies, all of these equations persistently 
testified progressive decrease in GFR overestimation 
and/or increase in GFR underestimation as graft 
function ameliorated [28,34,53].
The CKD-EPI equation[50] introduces a correction 
term to overcome the systematic underestimation of 
GFR of the MDRD formulas in patients with relatively 
well-preserved kidney function, as mentioned above. 
In a cohort of 207 stable Kidney transplant recipients[54] 
CKD-EPI shows improved estimation ability compared 
with MDRD equation, but still with suboptimal precision 
that limit the value of the CKD-EPI for monitoring 
changes in kidney function over time[54]. Other studies 
compare the performances of the MDRD and CKD-EPI 
equations in a large transplant patient’s cohort[55,56] and 
the authors concluded that the latter equation does 
not offer a better GFR estimation in this population. 
More recently, Shafﬁ et al[57], conducted a systematic 
evaluation of the development methods of all published 
Cr-based eGFR equations, and assess their performance 
in a large population (n = 3622) of solid-organ transplant 
recipients, including 53% kidney transplant recipients. 
They founded that the CKD-EPI[50] and IDMS-traceable 
4-variable MDRD Study equations[48] were more accurate 
than the alternative equations, including those developed 
in populations including only transplant recipients, and as 
accurate as observed in non-transplanted populations. 
Nevertheless, we can’t forget that these equations still 
misestimate true GFR by > 30% in 1 of 5 patients. 
They also concluded that there was no difference 
between these two equations in the overall study 
population, but CKD-EPI equation showed better 
performance at higher GFRs compared with better 
performance of MDRD Study equation at lower GFRs, 
which is in agreement with the results of the systematic 
review performed by Earley et al[58]. This study[57] may 
have implications in clinical practice, support the use of 
these eGFR equations to routine access renal function 
in transplant patients as in other populations. Even 
though it was a good diagnostic test study design with 
a standardized reference test, the study population 
included few nonwhites and individuals with solid 
organ transplants other than liver and kidneys; 
Santos J et al . Estimating glomerular filtration rate in kidney transplantation
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(CKD-EPI Cr-CyC 2012)[73], were validate in a European 
cohort of renal transplants patients[74] but their accuracy 
needs to be evaluated in more studies with this 
population.
CREATININE-BASED AND CYC-BASED 
eGFR EQUATIONS AS PREDICTORS OF 
CLINICAL OUTCOMES 
Although, it has been demonstrated that eGFR is a 
predictor of patient and transplant survival[75], disappointing 
results have been reported when several of Cr-based eGFR 
formulas where assessed against the most important 
outcome measures such as mortality and graft failure, with 
limited utility and no beneﬁt over the use of SCr alone[76].
Another relevant problem in clinical practice is 
whether the eGFR equations were able to precisely 
predict variations in graft function over time. Several 
studies reported considerable variability of the Cr-
based eGFR equations performance at different times 
post-transplant[28,77] with less accuracy within the ﬁrst 
year of transplantation[78], indicating that those Cr-
based equations must be worn with caution for GFR 
monitoring through time[79]. 
Nowadays there is an increasing interest in CyC-
based equations as an outcome predictor in kidney 
transplantation. In general population, CyC-based 
eGFR equations are a stronger predictor of the risk 
of death and cardiovascular events, when compared 
with Cr[80,81], as well as the correlation of serum CyC 
with all-cause and cardiovascular mortality in chronic 
kidney disease (CKD)[82]. Recently, a meta-analysis of 
11 general-population studies and 5 studies of cohorts 
with CKD[83], shows that the utilization of CyC alone or 
in combination with Cr reinforce the power of eGFR  as 
a predictor of end-stage renal disease  and death .
Whether this outcome prediction is true for transplant 
recipients needs to be conﬁrmed. Although, some studies 
showed that CyC and or CyC-based equations predicted 
both patient mortality and graft outcome better than Cr-
based eGFR equations[34,84], others founded that CyC and 
SCr were equally reliable predictors of graft outcome[85].
Interestingly, very recently, a study examined the 
extent to which the addition of serum CyC improves 
GFR estimation and mortality prediction, in comparison 
to various eGFR equations, in a population of 401 liver 
transplanted patients. In this work, the authors founded 
that CyC, by itself or as a part of an eGFR, was a 
signiﬁcant predictor of mortality[86].
Another approach is a multimarker management, 
including combination of different markers of graft 
function, such as SCr, CyC, and kidney pathologic 
markers, such as proteinuria and/or albuminuria. 
Models that include Cr-based or CyC-based eGFR and 
albuminuria show better prediction to end-stage renal 
disease in general population[87,88], and CKD patients[89]. 
A clinical score constructed from a cross-validated 
French database of 2169 kidney transplant recipients, 
combining risk factors of graft loss, including SCr and 
proteinuria, demonstrated to be highly predictive of 
long-term kidney graft survival[90], and other study 
demonstrated that the combination of low-grade 
albuminuria and decreased eGFR was related with graft 
loss and mortality[91].
In a similar way, a recent small-sample single-
center study[92] founded that predictors combining 
albuminuria and Cr- or CyC-based eGFR, performed 
better than those markers alone, to predict death 
censored graft loss, in kidney transplant recipients. 
Moreover, the best predictor of graft failure in this work 
was a product of CyC and the logarithm of albuminuria, 
and CyC-based predictors performed better than Cr-
based predictors. 
More recently, there has been some enthusiasm 
in new markers of kidney injury such as neutrophil 
gelatinase-associated lipocalin (NGAL) and kidney 
injury molecule-1 (KIM-1), and it potential in prediction 
of kidney function, not influenced by age, gender, 
race, body fat and muscle mass. Particularly, in 
kidney transplant recipients, it was demonstrated that 
urinary excretion of KIM-1, a proximal tubular protein, 
independently predicts graft failure[93]. However, more 
trials are required to validate these results in clinical 
setting. 
PROTEINURIA
Proteinuria, although not a direct GFR marker, is also 
an important indicator of allograft dysfunction[94,95], 
associated with a reduced long-term graft survival[94,95] 
and increased patient mortality[94,96].
One of the limitations of proteinuria as an accurate 
marker of graft dysfunction is the native kidney excretion, 
and in that cases, should have a baseline value before 
transplantation, particularly in the setting of pre-existing 
glomerular disease. However, pretransplant proteinuria 
decreases or disappears after successful transplantation 
and de novo or increasing proteinuria is indicative of graft 
pathology[97].
Proteinuria can signal pathologic changes including 
recurrent or de novo glomerular disease, calcineurin 
inhibitor toxicity, alloantibody-mediated injury and 
chronic allograft nephropathy[98]. In this way, graft 
biopsy helps to determine the etiology of proteinuria[20,99] 
and  to manage some treatable causes of graft injury. 
KDIGO guidelines[20] proposed monitoring of proteinuria 
as part of routine transplant follow-up.
CONCLUSION
An accurate evaluation of allograft function is crucial 
in the management of kidney transplant, and most 
importantly in predicting clinical outcomes. However 
any endogenous kidney function marker has limitations, 
and understandably, eGFR formulas derived from them 
will present similar barriers. Also, these prediction 
equations have inherent problems, namely the selected 
Santos J et al . Estimating glomerular filtration rate in kidney transplantation
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populations used for their derivation, usually non-
transplanted patients.
The Cr-based eGFR equations were the much widely 
used and recent studies, accessing the performance 
of MDRD study and CKD-EPI equations in kidney 
transplantation, support their use to routine access renal 
function in transplant patients as in other populations. 
But, we can’t forget that Cr-based eGFR equations 
have never been demonstrated to improve the clinical 
recognition of changes in transplant function, compared 
to the use of Cr alone, and many transplant injuries 
occur without change in SCr level or eGFR.
In the last years, our attention is moving toward 
another markers and CyC seems to be a promising 
one. Although, some conflicting results, several studies 
in kidney transplants confirm the better performance 
of CyC-based equations over Cr-based equations in 
estimating GFR. The use of CyC alone or in combination 
with Cr reinforces the eGFR power as a predictor of 
end-stage kidney disease and death, in general and 
CKD population, but we need to conﬁrm this outcome 
prediction in transplant recipients. However, like Cr, CyC 
is also influenced by non-GFR determinants, is more 
expensive than SCr and has suboptimal standardization, 
therefore its use is not widespread implemented. 
Finally, a model combining different markers such 
as SCr, CyC, proteinuria and/or albuminuria can be 
useful in clinical practice, providing an improvement 
in outcome prediction. At moment, and regarding the 
kidney transplant management, we are still searching 
for the optimal combination and for the best marker. 
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